[HTML][HTML] Prevalence of dyslipidemia, treatment rate and its control among patients with type 2 diabetes mellitus in Northwest China: a cross-sectional study

J Li, Z Nie, Z Ge, L Shi, B Gao, Y Yang - Lipids in Health and Disease, 2022 - Springer
Background The prevalence of cardiovascular disease (CVD) is high in China, especially in
Northwest China, and dyslipidemia in diabetes is a major factor at risk for CVD. The …

Prevalence of dyslipidemia, treatment rate and its control among patients with type 2 diabetes mellitus in Northwest China: a cross-sectional study.

J Li, Z Nie, Z Ge, L Shi, B Gao… - Lipids in Health & …, 2022 - search.ebscohost.com
Background: The prevalence of cardiovascular disease (CVD) is high in China, especially in
Northwest China, and dyslipidemia in diabetes is a major factor at risk for CVD. The …

Prevalence of dyslipidemia, treatment rate and its control among patients with type 2 diabetes mellitus in Northwest China: a cross-sectional study

J Li, Z Nie, Z Ge, L Shi, B Gao… - Lipids in health and …, 2022 - pubmed.ncbi.nlm.nih.gov
Background The prevalence of cardiovascular disease (CVD) is high in China, especially in
Northwest China, and dyslipidemia in diabetes is a major factor at risk for CVD. The …

[HTML][HTML] Prevalence of dyslipidemia, treatment rate and its control among patients with type 2 diabetes mellitus in Northwest China: a cross-sectional study

J Li, Z Nie, Z Ge, L Shi, B Gao… - Lipids in Health and …, 2022 - ncbi.nlm.nih.gov
Background The prevalence of cardiovascular disease (CVD) is high in China, especially in
Northwest China, and dyslipidemia in diabetes is a major factor at risk for CVD. The …

Prevalence of dyslipidemia, treatment rate and its control among patients with type 2 diabetes mellitus in Northwest China: a cross-sectional study.

J Li, Z Nie, Z Ge, L Shi, B Gao, Y Yang - Lipids in Health and …, 2022 - europepmc.org
Background The prevalence of cardiovascular disease (CVD) is high in China, especially in
Northwest China, and dyslipidemia in diabetes is a major factor at risk for CVD. The …

[HTML][HTML] Prevalence of dyslipidemia, treatment rate and its control among patients with type 2 diabetes mellitus in Northwest China: a cross-sectional study

J Li, Z Nie, Z Ge, L Shi, B Gao… - Lipids in Health and …, 2022 - lipidworld.biomedcentral.com
The prevalence of cardiovascular disease (CVD) is high in China, especially in Northwest
China, and dyslipidemia in diabetes is a major factor at risk for CVD. The dyslipidemia …

Prevalence of dyslipidemia, treatment rate and its control among patients with type 2 diabetes mellitus in Northwest China: a cross-sectional study

J Li, Z Nie, Z Ge, L Shi, B Gao, Y Yang - 2022 - agris.fao.org
Background The prevalence of cardiovascular disease (CVD) is high in China, especially in
Northwest China, and dyslipidemia in diabetes is a major factor at risk for CVD. The …

Prevalence of dyslipidemia, treatment rate and its control among patients with type 2 diabetes mellitus in Northwest China: a cross-sectional study

J Li, Z Nie, Z Ge, L Shi, B Gao… - Lipids in Health and …, 2022 - search.proquest.com
Background The prevalence of cardiovascular disease (CVD) is high in China, especially in
Northwest China, and dyslipidemia in diabetes is a major factor at risk for CVD. The …

[PDF][PDF] Prevalence of dyslipidemia, treatment rate and its control among patients with type 2 diabetes mellitus in Northwest China: a cross-sectional study

J Li, Z Nie, Z Ge, L Shi, B Gao, Y Yang - 2022 - lipidworld.biomedcentral.com
Background: The prevalence of cardiovascular disease (CVD) is high in China, especially in
Northwest China, and dyslipidemia in diabetes is a major factor at risk for CVD. The …